These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10684520)

  • 21. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacing.
    Tsai SF; Houmsse M; Dakhil B; Augostini R; Hummel JD; Kalbfleisch SJ; Liu Z; Love C; Rhodes T; Tyler J; Weiss R; Hamam I; Winner M; Daoud EG
    Heart Rhythm; 2014 Mar; 11(3):485-91. PubMed ID: 24252288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects.
    Piccirillo G; Magrì D; Matera S; Magnanti M; Pasquazzi E; Schifano E; Velitti S; Mitra M; Marigliano V; Paroli M; Ghiselli A
    Transl Res; 2008 May; 151(5):267-72. PubMed ID: 18433709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of sotalol on ventricular repolarization during exercise.
    Li J; Wang JA
    J Zhejiang Univ Sci B; 2005 Apr; 6(4):249-53. PubMed ID: 15754421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D; Dabrowski R; Szwed H; Gasior Z; Stanke A; Jasek S; Skrabucha B; Matar A; Kowalik I
    Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
    Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
    Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in cardiac repolarization following intravenous sotalol administration.
    Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of sotalol in idiopathic ventricular arrhythmia originating in the right ventricular outflow tract].
    Maia IG; Seixas TN; Costa AM; Peres AK; Magalhães Júnior A; Sá R; Alves PA
    Arq Bras Cardiol; 1994 Jul; 63(1):59-63. PubMed ID: 7857216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurately measured and properly heart-rate corrected QTc intervals show little daytime variability.
    Malik M; Hnatkova K; Schmidt A; Smetana P
    Heart Rhythm; 2008 Oct; 5(10):1424-31. PubMed ID: 18929329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QT interval correction assessment in the anesthetized guinea pig.
    Morissette P; Regan HK; Fitzgerald K; Bernasconi S; Gerenser P; Travis J; Fanelli P; Sannajust F; Regan CP
    J Pharmacol Toxicol Methods; 2015; 75():52-61. PubMed ID: 26001325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of 24-h Rhythm in Ventricular Repolarization Identifies QT Diurnality As a Novel Clinical Parameter Associated with Previous Ventricular Arrhythmias in Heart Failure Patients.
    Du Pre BC; Van Laake LW; Meine M; Van der Heijden JF; Doevendans PA; Vos MA; Van Veen TAB
    Front Physiol; 2017; 8():590. PubMed ID: 28861002
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment.
    Molnar J; Ranade V; Cvetanovic I; Molnar Z; Somberg JC
    Cardiology; 2006; 106(4):224-32. PubMed ID: 16685129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of frequency-dependence of ventricular repolarisation by the Holter method in young adults. Influence of the autonomic nervous system on the rate-dependence of QT].
    Catuli D; Maison-Blanche P; Fayn J; Rubel P; Larroque P; Vacheron A; Coumel P
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):927-34. PubMed ID: 9339253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
    Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
    J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.